Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome.
Germline mutations in the LKB1/STK11 tumour suppressor gene cause Peutz-Jeghers syndrome (PJS), a rare dominant disorder. In addition to typical hamartomatous gastrointestinal polyps and pigmented perioral lesions, PJS is associated with an increased risk of tumours at multiple sites. Follow-up info...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2003
|
| _version_ | 1797081460464680960 |
|---|---|
| author | Lim, W Hearle, N Shah, B Murday, V Hodgson, S Lucassen, A Eccles, D Talbot, I Neale, K Lim, A O'Donohue, J Donaldson, A Macdonald, R Young, I Robinson, M Lee, P Stoodley, B Tomlinson, I Alderson, D Holbrook, A Vyas, S Swarbrick, E Lewis, A Phillips, R Houlston, R |
| author_facet | Lim, W Hearle, N Shah, B Murday, V Hodgson, S Lucassen, A Eccles, D Talbot, I Neale, K Lim, A O'Donohue, J Donaldson, A Macdonald, R Young, I Robinson, M Lee, P Stoodley, B Tomlinson, I Alderson, D Holbrook, A Vyas, S Swarbrick, E Lewis, A Phillips, R Houlston, R |
| author_sort | Lim, W |
| collection | OXFORD |
| description | Germline mutations in the LKB1/STK11 tumour suppressor gene cause Peutz-Jeghers syndrome (PJS), a rare dominant disorder. In addition to typical hamartomatous gastrointestinal polyps and pigmented perioral lesions, PJS is associated with an increased risk of tumours at multiple sites. Follow-up information on carriers is limited and genetic heterogeneity makes counselling and management in PJS difficult. Here we report the analysis of the LKB1/STK11 locus in a series of 33 PJS families, and estimation of cancer risks in carriers and noncarriers. Germline mutations of LKB1/STK11 were identified in 52% of cases. This observation reinforces the hypothesis of a second PJS locus. In carriers of LKB1/STK11 mutations, the risk of cancer was markedly elevated. The risk of developing any cancer in carriers by age 65 years was 47% (95% CI: 27-73%) with elevated risks of both gastrointestinal and breast cancer. PJS with germline mutations in LKB1/STK11 are at a very high relative and absolute risk of multiple gastrointestinal and nongastrointestinal cancers. To obtain precise estimates of risk associated with PJS requires further studies of genotype-phenotype especially with respect to LKB1/STK11 negative cases, as this group is likely to be heterogeneous. |
| first_indexed | 2024-03-07T01:14:40Z |
| format | Journal article |
| id | oxford-uuid:8e3dfd1b-70f0-4fdb-9555-1baa803f16c0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:14:40Z |
| publishDate | 2003 |
| record_format | dspace |
| spelling | oxford-uuid:8e3dfd1b-70f0-4fdb-9555-1baa803f16c02022-03-26T22:56:28ZFurther observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8e3dfd1b-70f0-4fdb-9555-1baa803f16c0EnglishSymplectic Elements at Oxford2003Lim, WHearle, NShah, BMurday, VHodgson, SLucassen, AEccles, DTalbot, INeale, KLim, AO'Donohue, JDonaldson, AMacdonald, RYoung, IRobinson, MLee, PStoodley, BTomlinson, IAlderson, DHolbrook, AVyas, SSwarbrick, ELewis, APhillips, RHoulston, RGermline mutations in the LKB1/STK11 tumour suppressor gene cause Peutz-Jeghers syndrome (PJS), a rare dominant disorder. In addition to typical hamartomatous gastrointestinal polyps and pigmented perioral lesions, PJS is associated with an increased risk of tumours at multiple sites. Follow-up information on carriers is limited and genetic heterogeneity makes counselling and management in PJS difficult. Here we report the analysis of the LKB1/STK11 locus in a series of 33 PJS families, and estimation of cancer risks in carriers and noncarriers. Germline mutations of LKB1/STK11 were identified in 52% of cases. This observation reinforces the hypothesis of a second PJS locus. In carriers of LKB1/STK11 mutations, the risk of cancer was markedly elevated. The risk of developing any cancer in carriers by age 65 years was 47% (95% CI: 27-73%) with elevated risks of both gastrointestinal and breast cancer. PJS with germline mutations in LKB1/STK11 are at a very high relative and absolute risk of multiple gastrointestinal and nongastrointestinal cancers. To obtain precise estimates of risk associated with PJS requires further studies of genotype-phenotype especially with respect to LKB1/STK11 negative cases, as this group is likely to be heterogeneous. |
| spellingShingle | Lim, W Hearle, N Shah, B Murday, V Hodgson, S Lucassen, A Eccles, D Talbot, I Neale, K Lim, A O'Donohue, J Donaldson, A Macdonald, R Young, I Robinson, M Lee, P Stoodley, B Tomlinson, I Alderson, D Holbrook, A Vyas, S Swarbrick, E Lewis, A Phillips, R Houlston, R Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. |
| title | Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. |
| title_full | Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. |
| title_fullStr | Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. |
| title_full_unstemmed | Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. |
| title_short | Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. |
| title_sort | further observations on lkb1 stk11 status and cancer risk in peutz jeghers syndrome |
| work_keys_str_mv | AT limw furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT hearlen furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT shahb furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT murdayv furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT hodgsons furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT lucassena furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT ecclesd furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT talboti furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT nealek furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT lima furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT odonohuej furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT donaldsona furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT macdonaldr furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT youngi furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT robinsonm furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT leep furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT stoodleyb furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT tomlinsoni furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT aldersond furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT holbrooka furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT vyass furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT swarbricke furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT lewisa furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT phillipsr furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome AT houlstonr furtherobservationsonlkb1stk11statusandcancerriskinpeutzjegherssyndrome |